Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Donghoon, Yoon"'
Autor:
Syed Hassan Mehdi, Sana Nafees, Syed Jafar Mehdi, Carol A. Morris, Ladan Mashouri, Donghoon Yoon
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Multiple myeloma (MM) is a clonal B-cell disorder characterized by the proliferation of malignant plasma cells (PCs) in the bone marrow, the presence of monoclonal serum immunoglobulin, and osteolytic lesions. It is the second most common hematologic
Externí odkaz:
https://doaj.org/article/0a7d75ee2a6746ad826d2cbf74fb8552
Publikováno v:
Journal of Bone Oncology, Vol 12, Iss , Pp 19-22 (2018)
The 5TGM1 multiple myeloma transplanted C57BL6/KaLwRij model recapitulates many disease features including monoclonal paraprotein production as well as the development of osteolytic bone lesions. Since a significant association between serum parathyr
Externí odkaz:
https://doaj.org/article/03c3d551886542a3b361515fd8aa4b33
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2473
Multiple myeloma (MM) is the second most common hematological malignancy. It is a clonal B-cell disorder characterized by the proliferation of malignant plasma cells in the bone marrow, the presence of monoclonal serum immunoglobulin, and osteolytic
Publikováno v:
Cancer Research. 83:3828-3828
Multiple Myeloma (MM) is a plasma cell malignancy that, despite advances in treatment, remains incurable. In over 90% of MM patients, aberrant bone remodeling occurs and results in osteolytic lesions. Korean traditional medicine has a long-standing i
Publikováno v:
Cancers
Volume 13
Issue 17
Cancers, Vol 13, Iss 4277, p 4277 (2021)
Volume 13
Issue 17
Cancers, Vol 13, Iss 4277, p 4277 (2021)
Simple Summary Multiple myeloma is a plasma cell cancer involving bone destruction and is considered an incurable disease despite significant improvements in therapeutic strategies. During myeloma progression, over 90% of patients develop a bone dise
Autor:
Carol A Morris, Ladan Mashouri, Syed Jafar Mehdi, Syed Hassan Mehdi, Donghoon Yoon, Sana Nafees
Publikováno v:
Frontiers in Genetics
Frontiers in Genetics, Vol 12 (2021)
Frontiers in Genetics, Vol 12 (2021)
Multiple myeloma (MM) is a clonal B-cell disorder characterized by the proliferation of malignant plasma cells (PCs) in the bone marrow, the presence of monoclonal serum immunoglobulin, and osteolytic lesions. It is the second most common hematologic
Publikováno v:
Cancer Research. 82:1655-1655
Diffuse Large B-cell Lymphoma (DLBCL) is a commonly diagnosed aggressive non-Hodgkin’s lymphoma, with ~40% of patients experiencing the refractory or relapsed disease. The development of alternative therapies that target molecular features defining
Autor:
Nikica Ljubas Tomasic, Lucie Piterkova, Chad Huff, Ernest Bilic, Donghoon Yoon, Galina Y. Miasnikova, Adelina I. Sergueeva, Xiaomei Niu, Sergei Nekhai, Victor Gordeuk, Josef T. Prchal
Publikováno v:
Haematologica, Vol 98, Iss 4 (2013)
Mutations of VHL (a negative regulator of hypoxia-inducible factors) have position-dependent distinct cancer phenotypes. Only two known inherited homozygous VHL mutations exist and they cause polycythemia: Chuvash R200W and Croatian H191D. We report
Externí odkaz:
https://doaj.org/article/adef9eac38274f7f83d77908abbec6d2
Autor:
Maurizio Zangari, Bum Jin Kim, Yang Li, Donghoon Yoon, S. Michael Yu, Ik Jae Shin, Boi Hoa San, Lucas L. Bennink
Publikováno v:
Biomaterials. 183:67-76
Degradation of the extracellular matrix (ECM) is one of the fundamental factors contributing to a variety of life-threatening or disabling pathological conditions. However, a thorough understanding of the degradation mechanism and development of new
Publikováno v:
Journal of Bone Oncology
Journal of Bone Oncology, Vol 12, Iss, Pp 19-22 (2018)
Journal of Bone Oncology, Vol 12, Iss, Pp 19-22 (2018)
The 5TGM1 multiple myeloma transplanted C57BL6/KaLwRij model recapitulates many disease features including monoclonal paraprotein production as well as the development of osteolytic bone lesions. Since a significant association between serum parathyr